Table 2

Demographics of the patients enrolled in a National CRC Surveillance Program
Variable Surgeon-surveillance n = 55 (%) GP-surveillance n = 55 (%) Total n = 110 (%) p value
Mean age (SD) 66.7 (7.3) 64.0 (8.7) 65.4 (8.1) ns
Male 32 (58.2) 33 (60.0) 65 (59.1) ns
Female 23 (41.8) 22 (40.0) 45 (40.9) ns
Tumour location
Coecum 13 (23.6) 13 (23.6) 26 (23.6) ns
Ascendens 9 (16.3) 5 (9.1) 14 (12.7) ns
Transversum 4 (7.2) 5 (9.1) 9 (8.1) ns
Decendens 1 (1.8) 4 (1.8) 5 (4.5) ns
Sigmoid 28 (50.9) 28 (50.9) 56 (50.9) ns
Type of surgery
Laparoscopic 14 (25.5) 11 (20.0) 25 (22.7) ns
Open 41 (74.5) 44 (80.0) 85 (77.3) ns
Tumour stage
Dukes A 12 (21.8) 11 (20.0) 24 (21.8) ns
Dukes B 25 (45.5) 30 (54.5) 55 (50.0) ns
Dukes C 18 (32.7) 14 (25.5) 32 (29.0) ns
Total surveillance months 942 942 1884 ns
Median surveillance (months) 17 17 17 NA
Surveillance tests n 513 592 1105 ns
Carcinoembryonic antigen CEA (%) 203 (39) 300 (51) 503 <0.001
Chest X-ray (%) 150 (29) 128 (21) 278 0.003
Liver ultrasound (%) 110 (21) 99 (17) 209 0.03
Colonoscopy (%) 50 (9) 65 (11) 115 ns
Consultations n 508 678 1186 ns

Augestad et al.

Augestad et al. BMC Health Services Research 2014 14:137   doi:10.1186/1472-6963-14-137

Open Data